2019. Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S38. DOI:https://doi.org/10.25251/skin.3.supp.38.